This 1999 study evaluated the safety of estrogen replacement therapy (ERT) in 76 women with a history of breast cancer, including 50 who used ERT for up to 32 years. The findings indicated that ERT did not increase the risk of cancer recurrence or mortality. Additionally, the addition of progestogens
